$TPB

Vietnamese banks are accelerating charter-capital increases via bonus shares, stock dividends and rights issues. BIDV plans a 498.2m-share bonus issuance (record Aug 18) and a 4.5% cash dividend (Aug 20). Vietcombank and VietinBank also plan 4.5% cash dividends in late August. Other lenders including MBBank, HDBank, TPBank, VIB, Maritime Bank, VietABank and Vietbank outline additional share issuances and a Vietbank rights offer.

HOSE reported that in Q2, 366 of 396 listed firms were profitable and 30 posted losses, generating VND220 trillion in after-tax profit. VN30 stocks contributed about VND165 trillion, around 75%. VIC and VCB drove most of the VN30 profit increase. HPG saw the biggest decline. HOSE added MCH and TCX to VN30 effective Aug 3, removing PLX and TPB.

Turning Point Brands (NYSE:TPB) reported Q2 segment updates and raised 2026 Modern Oral outlook. Adjusted gross sales guidance for Modern Oral increased to $330M-$350M and net sales to $260M-$270M. It kept full-year adjusted EBITDA at $70M-$90M. The company said it ended Q2 with $268M cash and $26M free cash flow, helped by an $18M tariff refund.

Turning Point Brands, Inc. (TPB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Turning Point Brands Announces Second Quarter 2026 Results ● Q2 2026 Modern Oral Gross Revenue increased 149% to $87.0 million and Net Sales increased 128% to $68.4 million. Accounting for 48% of total company net sales, up from 26% in Q2 2025 ● Raising FY 2026 Moder

Turning Point Brands (NYSE:TPB) reported first-quarter results on May 7. Revenue rose 17% year over year to $124.3 million, driven by growth in its Modern Oral nicotine pouch segment. Gross profit increased 14.6% to $68.3 million, while adjusted EBITDA fell 6.5% to $25.9 million as margins contracted to 20.8%. The company said it is investing in sales, marketing, and manufacturing and targets double-digit market share by 2030.

Crown Advisors Management, Inc. reduced its stake in Turning Point Brands (NYSE:TPB) by 35,000 shares, an estimated $3.90 million trade, in the first quarter of 2026. This divestment occurred despite Turning Point Brands being a diversified consumer products company focused on tobacco and next-generation alternatives with strong market positions. The fund's holding value in TPB decreased by $4.12 million, reflecting both the share sale and underlying price changes.

M&T Bank Corp significantly increased its stake in Turning Point Brands, Inc. (NYSE:TPB) by 712.5% in the fourth quarter, now owning 19,499 shares valued at approximately $2.11 million. This makes M&T Bank Corp a 0.10% owner of the company, which has an overall institutional ownership of about 96.1%. Despite this, some insider selling occurred, with CFO Andrew Flynn reducing his holding by 17.48% in March.

Turning Point Brands (TPB) stock fell 15.5% this week due to reports of slower Food and Drug Administration (FDA) approvals for nicotine pouches, a fast-growing segment for the company. The FDA's hesitation stems from concerns over unknown health impacts and use among younger individuals, reminiscent of the vaping epidemic. Despite the company's stock being down significantly from its highs, its diverse revenue streams from rolling papers, chewing tobacco, and nicotine pouches could make it an attractive buy for investors who see the FDA issues as a temporary setback.

The article discusses the reasons behind the significant drop in Turning Point Brands stock this week. Investors reacted negatively to a ruling from the U.S. International Trade Commission and a subsequent short-seller report. These events raise concerns about the company's vaping product sales and its overall financial outlook.

Turning Point Brands (TPB) faces temporary profitability headwinds in 2026 due to cautious guidance and increased spending on its nicotine pouch business, despite strong recent fundamentals. Its most followed narrative suggests the stock is undervalued at $121.25 compared to its current price of $92.88, driven by growth in premium brands. However, a market multiple perspective shows a P/E ratio above industry averages, indicating potentially full pricing for its growth forecasts, suggesting investors should consider both the undervaluation narrative and potential risks.